Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Mankind Pharma Gelecekteki Büyüme
Future kriter kontrolleri 3/6
Mankind Pharma is forecast to grow earnings and revenue by 16.5% and 11.8% per annum respectively. EPS is expected to grow by 16.2% per annum. Return on equity is forecast to be 20.6% in 3 years.
Anahtar bilgiler
16.5%
Kazanç büyüme oranı
16.2%
EPS büyüme oranı
| Pharmaceuticals kazanç büyümesi | 18.1% |
| Gelir büyüme oranı | 11.8% |
| Gelecekteki özkaynak getirisi | 20.6% |
| Analist kapsamı | Good |
| Son güncelleme | 30 Sep 2024 |
Gelecekteki son büyüme güncellemeleri
Recent updates
Here's Why Mankind Pharma (NSE:MANKIND) Can Manage Its Debt Responsibly
Aug 26
Risks To Shareholder Returns Are Elevated At These Prices For Mankind Pharma Limited (NSE:MANKIND)
Jul 12Here's Why Mankind Pharma (NSE:MANKIND) Has Caught The Eye Of Investors
May 08Mankind Pharma Limited's (NSE:MANKIND) Business Is Trailing The Market But Its Shares Aren't
Apr 08Mankind Pharma Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Feb 04Kazanç ve Gelir Büyüme Tahminleri
| Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
|---|---|---|---|---|---|
| 3/31/2027 | 147,510 | 30,995 | 28,266 | N/A | 7 |
| 3/31/2026 | 130,672 | 26,078 | 23,731 | N/A | 12 |
| 3/31/2025 | 115,883 | 22,021 | 20,517 | N/A | 11 |
| 6/30/2024 | 106,496 | 19,625 | N/A | N/A | N/A |
| 3/31/2024 | 103,348 | 19,129 | 17,701 | 21,524 | N/A |
| 12/31/2023 | 99,463 | 17,271 | N/A | N/A | N/A |
| 9/30/2023 | 94,303 | 15,575 | 14,862 | 20,644 | N/A |
| 6/30/2023 | 91,481 | 14,762 | N/A | N/A | N/A |
| 3/31/2023 | 87,494 | 12,819 | 9,812 | 18,133 | N/A |
| 12/31/2022 | 84,225 | 11,865 | -15,564 | 10,901 | N/A |
| 3/31/2022 | 77,816 | 14,335 | -14,257 | 9,198 | N/A |
| 3/31/2021 | 62,144 | 12,654 | 8,249 | 11,372 | N/A |
| 3/31/2020 | 58,719 | 10,304 | 8,442 | 10,722 | N/A |
| 3/31/2019 | 49,800 | 5,785 | 3,027 | 6,004 | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: MANKIND's forecast earnings growth (16.5% per year) is above the savings rate (6.7%).
Kazançlar ve Piyasa: MANKIND's earnings (16.5% per year) are forecast to grow slower than the Indian market (17.2% per year).
Yüksek Büyüme Kazançları: MANKIND's earnings are forecast to grow, but not significantly.
Gelir ve Pazar: MANKIND's revenue (11.8% per year) is forecast to grow faster than the Indian market (10.1% per year).
Yüksek Büyüme Geliri: MANKIND's revenue (11.8% per year) is forecast to grow slower than 20% per year.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: MANKIND's Return on Equity is forecast to be high in 3 years time (20.6%)